Tofacitinib brand name is Xeljanz.

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $9.99Unlock all

Enhance your dermatological knowledge with the Dermatology Week 1 Exam. Engage with multiple choice questions that provide insights and detailed explanations to gear you up for testing success. Prepare effectively for your exam!

Multiple Choice

Tofacitinib brand name is Xeljanz.

Explanation:
Tofacitinib is marketed under the brand name Xeljanz. This question checks your ability to match a generic drug name to its trade name. Tofacitinib is a JAK inhibitor taken orally for inflammatory conditions, and Xeljanz is its brand. The other names correspond to different drugs: Humira is adalimumab, Remicade is infliximab, and Enbrel is etanercept, none of which are tofacitinib.

Tofacitinib is marketed under the brand name Xeljanz. This question checks your ability to match a generic drug name to its trade name. Tofacitinib is a JAK inhibitor taken orally for inflammatory conditions, and Xeljanz is its brand. The other names correspond to different drugs: Humira is adalimumab, Remicade is infliximab, and Enbrel is etanercept, none of which are tofacitinib.

More Multiple Choice Questions
Subscribe

Get the latest from Examzify

You can unsubscribe at any time. Read our privacy policy